We are live on ! Find out more
ICCC icon

ImmuCell
ICCC

25 hedge funds and large institutions have $5.39M invested in ImmuCell in 2024 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

1.42% less ownership

Funds ownership: 14.54% → 13.13% (-1.4%)

6% less capital invested

Capital invested by funds: $5.74M → $5.39M (-$347K)

11% less funds holding

Funds holding: 28 → 25 (-3)

25% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 8

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

Holders
25
Holders Change
-3
Holders Change %
-10.71%
% of All Funds
0.36%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
6
Reduced
8
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$50.1K
2
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$30.6K
3
UBS Group
UBS Group
Switzerland
+$15.2K
4
HighTower Advisors
HighTower Advisors
Illinois
+$515
5
JP Morgan Chase
JP Morgan Chase
New York
+$21

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$538K
2
MWM
Mission Wealth Management
California
-$50.9K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$43.8K
4
Northern Trust
Northern Trust
Illinois
-$13.7K
5
Renaissance Technologies
Renaissance Technologies
New York
-$6.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.15M +$50.1K +9,721 +5%
Renaissance Technologies
2
Renaissance Technologies
New York
$662K -$6.7K -1,300 -1%
CAM
3
Cresset Asset Management
Illinois
$549K – – –
BL
4
Bleichroeder LP
New York
$538K – – –
Morgan Stanley
5
Morgan Stanley
New York
$343K -$538K -104,432 -62%
Dimensional Fund Advisors
6
Dimensional Fund Advisors
Texas
$336K +$30.6K +5,950 +10%
SRC
7
Shufro Rose & Co
New York
$331K – – –
Geode Capital Management
8
Geode Capital Management
Massachusetts
$282K – – –
OMC
9
Overbrook Management Corp
New York
$174K – – –
SFS
10
Strategic Financial Services
New York
$164K – – –
Northern Trust
11
Northern Trust
Illinois
$159K -$13.7K -2,651 -8%
Susquehanna International Group
12
Susquehanna International Group
Pennsylvania
$134K -$43.8K -8,507 -25%
HighTower Advisors
13
HighTower Advisors
Illinois
$115K +$515 +100 +0.5%
PP
14
Prosperity Planning
Missouri
$84.8K – – –
WE
15
Wealth Effects
Massachusetts
$81.7K – – –
BlackRock
16
BlackRock
New York
$78.7K -$3.38K -657 -4%
MFIM
17
Mesirow Financial Investment Management
Illinois
$64.5K – – –
EFS
18
Essex Financial Services
Connecticut
$58.3K – – –
HPC
19
HM Payson & Co
Maine
$31.8K – – –
UBS Group
20
UBS Group
Switzerland
$23.6K +$15.2K +2,950 +197%
Wells Fargo
21
Wells Fargo
California
$13.5K +$10 +2 +0.1%
Bank of America
22
Bank of America
North Carolina
$10.8K -$15 -3 -0.1%
TRCT
23
Tower Research Capital (TRC)
New York
$10.6K -$314 -61 -3%
JP Morgan Chase
24
JP Morgan Chase
New York
$69 +$21 +4 +44%
MWM
25
Mission Wealth Management
California
– -$50.9K -10,000 Closed
1
2

ICCC Hedge Fund Activity: Q1 2024 in Review

25 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in ImmuCell (ICCC) for Q1 2024, worth a combined $5.39M — down 6% from $5.74M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of ICCC and 0 opened new positions — a net loss of 3 holders — while 8 trimmed existing stakes and 6 added.

The largest buyer was Vanguard Group, adding an estimated $50.1K. The largest seller was Morgan Stanley, cutting an estimated $538K.

  • 25 institutional investors held ImmuCell (ICCC) as of Q1 2024, down from 28 in Q4 2023.
  • Funds reported $5.39M of ImmuCell stock for Q1 2024, down 6% quarter-over-quarter.
  • 0 funds opened new ImmuCell positions in Q1 2024 and 3 closed out, a net change of -3 holders.
  • The largest ImmuCell buyer in Q1 2024 was Vanguard Group, an estimated $50.1K added.
  • The largest ImmuCell seller in Q1 2024 was Morgan Stanley, an estimated $538K sold.

Based on aggregated 13F filings for Q1 2024.